OTCMKTS:MJNA Medical Marijuana (MJNA) Stock Forecast, Price & News $0.0061 +0.00 (+5.17%) (As of 04:27 PM ET) Add Compare Share Share Today's Range$0.0055▼$0.006850-Day Range N/A52-Week Range$0.0026▼$0.0147Volume11.46 million shsAverage Volume5.93 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About Medical Marijuana (OTCMKTS:MJNA) StockMedical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry. In addition, it offers RSHO oil for the treatment of various illnesses and conditions; and plant-based, non-GMO pet products for health and wellness, play and wear, and environmentally-friendly supplies. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California.Read More MJNA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MJNA Stock News HeadlinesSeptember 27, 2023 | omaha.comMost Online Marijuana Dispensaries Lack Adequate Age VerificationSeptember 27, 2023 | news.yahoo.comSenate committee advances marijuana banking billSeptember 27, 2023 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>September 27, 2023 | wsj.comMarijuana Banking Bill Advanced by Senate PanelSeptember 22, 2023 | msn.comWhat to know about Issue 2, recreational marijuana legalization, as voting beginsSeptember 20, 2023 | detroitnews.comEx-Michigan Senate leader helped Rick Johnson land marijuana licensing jobSeptember 13, 2023 | msn.comSignatures being collected to put medical marijuana on Nebraska ballotSeptember 13, 2023 | msn.comAlabama medical marijuana commission falsely claimed bidder had criminal history, lawsuit allegesSeptember 27, 2023 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>September 13, 2023 | omaha.comNebraska's third medical marijuana ballot initiative kicks off petition driveSeptember 12, 2023 | news.yahoo.comMarijuana and the resurgence of a Cherokee chief in the mountains of North CarolinaSeptember 11, 2023 | news.yahoo.comHigh or not, Pa.'s medical marijuana law could land you a DUI. Here's whySeptember 6, 2023 | msn.comNJ marijuana: Mother-and-son team almost ready to open first Jersey Shore grow facilitySeptember 5, 2023 | msn.comPa. State Senator: Medical marijuana card is no proof of DUI, laws should changeSeptember 1, 2023 | msn.comThe state of marijuana legalization in the U.S.September 1, 2023 | msn.comAlabama medical marijuana licenses paused againAugust 31, 2023 | msn.comHealth Dept. on Marijuana: It Shouldn't Be a Schedule I DrugAugust 30, 2023 | msn.comHow marijuana impacts pain, sleep, anxiety and more, according to the latest scienceAugust 30, 2023 | msn.comFederal health agency recommends easing marijuana restrictionsAugust 30, 2023 | msn.comFederal health officials recommend reclassifying marijuanaAugust 30, 2023 | msn.comCannabis stocks rally amid reports DEA may reclassify drug as less riskyAugust 30, 2023 | msn.comFor some reason, NYS legalized Marijuana.August 29, 2023 | msn.comMedical Report: Marijuana use during pregnancy on the riseAugust 28, 2023 | msn.comJuly data pushes Arkansas medical marijuana sales to $164 million so far in 2023August 26, 2023 | investing.comMedical Marijuana, I (MJNA)August 25, 2023 | foxnews.comLegal fight over distribution of medical marijuana license in Alabama continuesAugust 23, 2023 | markets.businessinsider.comIs Legal Recreational Cannabis Wrecking Medical Marijuana Sales? Analyst Crunches The NumbersSee More Headlines Receive MJNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medical Marijuana and its competitors with MarketBeat's FREE daily newsletter. Email Address MJNA Company Calendar Today9/27/2023Next Earnings (Estimated)11/16/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers—Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolOTCMKTS:MJNA CUSIPN/A CIKN/A Webwww.medicalmarijuanainc.com Phone(866) 273-8502FaxN/AEmployees91Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Timothy Richard Scott Ph.D. (Age 70)CEO, Pres & Chairman Mr. Tyler WhatcottChief Technology OfficerMs. Michelle L. Sides Esq.Chief Legal OfficerDr. Rubens WajnsztejnChief Medical OfficerDr. George E. Anastassov DDS (Age 60)M.D., MBA, Member of Advisory Board and Chief Exec. Officer of Canchew Biotechnologies Key CompetitorsMarijuana Company of AmericaOTCMKTS:MCOAOWC Pharmaceutical ResearchOTCMKTS:OWCPWEEDOTCMKTS:BUDZ1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATVView All Competitors MJNA Stock - Frequently Asked Questions How have MJNA shares performed in 2023? Medical Marijuana's stock was trading at $0.0061 on January 1st, 2023. Since then, MJNA shares have increased by 0.0% and is now trading at $0.0061. View the best growth stocks for 2023 here. Are investors shorting Medical Marijuana? Medical Marijuana saw a drop in short interest in August. As of August 31st, there was short interest totaling 9,800 shares, a drop of 56.3% from the August 15th total of 22,400 shares. Based on an average trading volume of 17,530,300 shares, the short-interest ratio is presently 0.0 days. View Medical Marijuana's Short Interest. When is Medical Marijuana's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 16th 2023. View our MJNA earnings forecast. What other stocks do shareholders of Medical Marijuana own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Marijuana investors own include KushCo (KSHB), Organigram (OGI), American Cannabis (AMMJ), CNBX Pharmaceuticals (CNBX), MassRoots (MSRT), Auxly Cannabis Group (CBWTF), Smart Cannabis (SCNA), GB Sciences (GBLX), Diamond Wellness (POTN) and Gran Tierra Energy (GTE). What is Medical Marijuana's stock symbol? Medical Marijuana trades on the OTCMKTS under the ticker symbol "MJNA." How do I buy shares of Medical Marijuana? Shares of MJNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Medical Marijuana's stock price today? One share of MJNA stock can currently be purchased for approximately $0.01. How can I contact Medical Marijuana? Medical Marijuana's mailing address is 12255 Crosthwaite Cir, POWAY, CA 92064-8825, United States. The official website for the company is www.medicalmarijuanainc.com. The company can be reached via phone at (866) 273-8502. This page (OTCMKTS:MJNA) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medical Marijuana, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.